Tamiflu Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Prophylactic Treatment With Oseltamivir
Condition:   Influenza, Human Interventions:   Drug: Oseltamivir Oral Capsule for 5 days post-exposure;   Drug: Oseltamivir Oral Capsule for 10 days post-exposure Sponsor:   University Medical Centre Ljubljana Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2019 Category: Research Source Type: clinical trials